Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Haude

Showing results (101-110 of 208) with videos related to

Pageof 21
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 10, 2023
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trialTon Slagboom, Ralph Toelg, Bernhard Witzenbichler, et al.
Lancet (London, England)|January 22, 2013
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trialMichael Haude, Raimund Erbel, Paul Erne, et al.
Basic Research in Cardiology|April 8, 2011
Acute vasomotor paralysis and potential downstream effects of paclitaxel from stents implanted for saphenous vein aorto-coronary bypass stenosisPetra Kleinbongard, Dirk Böse, Thomas Konorza, et al.
Journal of the American College of Cardiology|January 29, 2013
FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship StudyRon Waksman, Jacek Legutko, Jasvindar Singh, et al.
BMC Cardiovascular Disorders|May 15, 2015
Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settingsOleg Borisenko, Michael Haude, Uta C Hoppe, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2023
One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registryAdrian Wlodarczak, Piero Montorsi, Jan Torzewski, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 28, 2002
Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patientsHolger Eggebrecht, Michael Haude, Uta Woertgen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 7, 2019
The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stentMichael Haude, Stephen W L Lee, Stephen G Worthley, et al.
The American Journal of Cardiology|August 8, 2009
Effectiveness and safety of percutaneous coronary sinus-based mitral valve repair in patients with dilated cardiomyopathy (from the AMADEUS trial)Tomasz Siminiak, Uta C Hoppe, Joachim Schofer, et al.
Journal of the American College of Cardiology|July 31, 2010
Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI TrialUwe Zeymer, Alain Margenet, Michael Haude, et al.
Pageof 21

Showing results (101-110 of 208) with videos related to

Sort By:
Pageof 21
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 10, 2023
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trialTon Slagboom, Ralph Toelg, Bernhard Witzenbichler, et al.
Lancet (London, England)|January 22, 2013
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trialMichael Haude, Raimund Erbel, Paul Erne, et al.
Basic Research in Cardiology|April 8, 2011
Acute vasomotor paralysis and potential downstream effects of paclitaxel from stents implanted for saphenous vein aorto-coronary bypass stenosisPetra Kleinbongard, Dirk Böse, Thomas Konorza, et al.
Journal of the American College of Cardiology|January 29, 2013
FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship StudyRon Waksman, Jacek Legutko, Jasvindar Singh, et al.
BMC Cardiovascular Disorders|May 15, 2015
Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settingsOleg Borisenko, Michael Haude, Uta C Hoppe, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2023
One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registryAdrian Wlodarczak, Piero Montorsi, Jan Torzewski, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 28, 2002
Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patientsHolger Eggebrecht, Michael Haude, Uta Woertgen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 7, 2019
The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stentMichael Haude, Stephen W L Lee, Stephen G Worthley, et al.
The American Journal of Cardiology|August 8, 2009
Effectiveness and safety of percutaneous coronary sinus-based mitral valve repair in patients with dilated cardiomyopathy (from the AMADEUS trial)Tomasz Siminiak, Uta C Hoppe, Joachim Schofer, et al.
Journal of the American College of Cardiology|July 31, 2010
Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI TrialUwe Zeymer, Alain Margenet, Michael Haude, et al.
Pageof 21